Metarmor Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $359K
Latest Deal Amount

Metarmor General Information

Description

Developer of drug for prevention of hearing loss. The company specializes in developing and commercializing a drug that protects hair cells in the inner ear for prevention of hearing loss and auditory damage.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 307 North Polktown Road
  • Glen Gardner, NJ 08826
  • United States
+1 (908) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Metarmor Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 09-Jun-2017 $359K 00000 Completed Startup
To view Metarmor’s complete valuation and funding history, request access »

Metarmor Executive Team (1)

Name Title Board Seat Contact Info
Jennifer Seibert Chief Executive Officer & Board Member
To view Metarmor’s complete executive team members history, request access »

Metarmor Board Members (4)

Name Representing Role Since
Frances Engoron Metarmor Board Member 000 0000
Jennifer Seibert Metarmor Chief Executive Officer & Board Member 000 0000
Joseph Walker Metarmor Board Member 000 0000
Kathleen Campbell Metarmor Board Member 000 0000
To view Metarmor’s complete board members history, request access »